International Journal of Biological Macromolecules Impact Factor

The 8.5 JIF means that papers in IJBM are well-cited within the JCR window. That's a strong number for a biochemistry journal, and the Q1 ranking at 6/94 is genuinely impressive on paper. The five-year JIF (8.7) tracking close to the two-year number indicates stable citation performance without significant front-loading or long-tail effects.

But context matters here more than at most journals. IJBM publishes more than 8,400 articles per year, making it one of the highest-volume Q1 journals in all of biochemistry. That volume has implications:

Selectivity is moderate. Despite the Q1 ranking, acceptance rates are higher than you'd expect for a journal at this JIF. The editorial model can accommodate a large number of solid papers, which means the bar for acceptance is lower than a journal like Biomacromolecules (fewer papers, tighter review).

Per-paper visibility is diluted. With 8,400+ articles competing for reader attention annually, individual papers get less editorial promotion and less organic visibility than they would at a lower-volume venue. The JIF measures average citation performance across all papers, and a journal this large will have wide variance between its most-cited and least-cited articles.

The prestige signal is weaker than the number suggests. Hiring committees and grant reviewers who understand journal publishing dynamics will read an IJBM publication differently from a Carbohydrate Polymers publication at a lower JIF, because they know the volume context. This isn't necessarily disqualifying, but it's worth being honest about.

• how competitive the acceptance rate actually is (lower than you'd assume for Q1)
• how visible your specific paper will be within 8,400+ annual articles
• how hiring committees read IJBM versus lower-volume biochemistry journals
• whether the macromolecule characterization is sufficient for this audience
• how long peer review will take

IJBM editors want clear characterization of biological macromolecules with defined application or mechanistic insight. The most common desk rejections come from papers that report basic characterization without a clear story, or that use macromolecule work as a thin wrapper for what is really a drug delivery or food science paper.

Papers on protein structure-function, polysaccharide-based biomaterials, and biopolymer applications tend to perform well. The journal has grown substantially in areas like chitosan-based materials, protein aggregation, and starch modification.

Submit if:

• the paper has clear biological macromolecule content with defined characterization
• you want a well-indexed, high-volume venue with realistic acceptance odds
• the work is solid but not aimed at a more selective specialty journal
• speed and Elsevier indexing matter for your timeline

Think twice if:

• Carbohydrate Polymers or a more specialized journal would give better-targeted visibility
• career context requires the prestige signal of a lower-volume, more selective journal
• the macromolecule angle is secondary to the real contribution (drug delivery, food tech)
• Biomacromolecules would provide a better ACS brand signal for your audience